









市場行情
/
股票
/
nasdaq-cdna
/

CareDx Inc

CDNA

19.450USD

+0.260+1.35%

收盤 12/19, 16:00（美東）報價延遲15分鐘

999.87M總市值

14.42本益比TTM



CareDx Inc

19.450

+0.260+1.35%

概覽公司財務分析

概覽

公司

財務

分析

關於 CareDx Inc 公司

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.

CareDx Inc簡介



公司代碼CDNA

公司名稱CareDx Inc

上市日期Jul 17, 2014

CEOHanna (John W)

員工數量644

證券類型Ordinary Share

年結日Jul 17

公司地址8000 Marina Blvd

城市BRISBANE

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編94005

電話14152872300

網址https://www.caredx.com/

公司代碼CDNA

上市日期Jul 17, 2014

CEOHanna (John W)

CareDx Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Mr. Michael D. Goldberg

Independent Chairman of the Board

145.40K

+1.22%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

Ms. Christine M. Cournoyer

Independent Director

38.58K

+45.71%

Mr. Suresh Gunasekaran

Director

27.45K

Mr. Jeffrey Adam Novack

General Counsel, Secretary

10.20K

-41.70%

Ms. Caroline Corner

Investor Relations

名稱

名稱/職務

職務

持股

持股變動

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Mr. Michael D. Goldberg

Independent Chairman of the Board

145.40K

+1.22%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

收入明細

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Testing Service revenue

62.03M

0.00%

Digital and other revenue

12.81M

0.00%

Product revenue

11.83M

0.00%

地區USD

名稱

營收

佔比

United States

81.64M

0.00%

Rest of the world

5.04M

0.00%

業務

地區

業務USD

名稱

營收

佔比

Testing Service revenue

62.03M

0.00%

Digital and other revenue

12.81M

0.00%

Product revenue

11.83M

0.00%

股東統計

更新時間: 11月17日週一

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

8.01%

The Vanguard Group, Inc.

7.27%

Baron Capital Management, Inc.

6.13%

State Street Investment Management (US)

4.99%

Ophir Asset Management Pty Ltd

4.27%

其他

69.32%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

8.01%

The Vanguard Group, Inc.

7.27%

Baron Capital Management, Inc.

6.13%

State Street Investment Management (US)

4.99%

Ophir Asset Management Pty Ltd

4.27%

其他

69.32%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

41.33%

Investment Advisor

35.53%

Hedge Fund

21.21%

Individual Investor

3.80%

Research Firm

3.27%

Pension Fund

0.59%

Bank and Trust

0.39%

Insurance Company

0.04%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

443

52.64M

115.22%

+43.46K

2025Q3

457

52.61M

115.96%

-1.80M

2025Q2

454

53.72M

112.39%

-1.85M

2025Q1

443

55.89M

106.19%

-3.01M

2024Q4

439

52.97M

108.30%

+1.05M

2024Q3

434

51.58M

120.50%

-825.62K

2024Q2

407

52.51M

127.45%

-1.22M

2024Q1

435

53.86M

132.45%

-14.73M

2023Q4

448

52.78M

128.80%

-2.04M

2023Q3

476

54.42M

142.26%

-1.69M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

4.07M

7.64%

-142.46K

-3.39%

Jun 30, 2025

The Vanguard Group, Inc.

4.90M

9.21%

+76.50K

+1.59%

Jun 30, 2025

Baron Capital Management, Inc.

2.44M

4.58%

+245.65K

+11.22%

Jun 30, 2025

State Street Investment Management (US)

2.18M

4.1%

-304.45K

-12.25%

Jun 30, 2025

Ophir Asset Management Pty Ltd

1.89M

3.56%

+274.63K

+16.97%

Jun 30, 2025

ARK Investment Management LLC

2.10M

3.95%

-247.22K

-10.53%

Jun 30, 2025

Amova Asset Management Co., Ltd.

1.24M

2.32%

-139.83K

-10.16%

Jun 30, 2025

Gagnon Securities LLC

2.13M

4.01%

+585.21K

+37.78%

Jul 17, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

ARK Genomic Revolution ETF

2.89%

ROBO Global Healthcare Technology & Innovation ETF

1.93%

Global X Genomics & Biotechnology ETF

0.87%

Franklin Genomic Advancements ETF

0.72%

State Street SPDR S&P Biotech ETF

0.34%

Direxion Daily S&P Biotech Bull 3X Shares

0.21%

iShares Micro-Cap ETF

0.16%

Fidelity Enhanced Small Cap ETF

0.11%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.11%

Principal U.S. Small-Cap ETF

0.1%

ARK Genomic Revolution ETF

佔比2.89%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.93%

Global X Genomics & Biotechnology ETF

佔比0.87%

Franklin Genomic Advancements ETF

佔比0.72%

State Street SPDR S&P Biotech ETF

佔比0.34%

Direxion Daily S&P Biotech Bull 3X Shares

佔比0.21%

iShares Micro-Cap ETF

佔比0.16%

Fidelity Enhanced Small Cap ETF

佔比0.11%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.11%

Principal U.S. Small-Cap ETF

佔比0.1%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

CareDx Inc的前五大股東是誰？



CareDx Inc的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：4.07M
佔總股份比例：7.64%。
The Vanguard Group, Inc.
持有股份：4.90M
佔總股份比例：9.21%。
Baron Capital Management, Inc.
持有股份：2.44M
佔總股份比例：4.58%。
State Street Investment Management (US)
持有股份：2.18M
佔總股份比例：4.10%。
Ophir Asset Management Pty Ltd
持有股份：1.89M
佔總股份比例：3.56%。